Interestingly, also in breast cancer, fewer CTCs have been reported for brain metastatic patients when analyzed by the CellSearch system [26], and those CTCs that were competent to colonize the brain as a distant target organ site were predominantly EpCAM-negative but EGFR, NOTCH1 and HPSE-positive [31]. Here, EPCAM is linked to breast carcinoma.